Researchers have identified an experimental agent that targets chronic lymphocytic leukemia and perhaps other proliferative disorders of lymphocytes.
An antibiotic appears to be a safe treatment for stroke and a good companion therapy for tPA, the clot buster that is currently the only FDA-approved drug therapy, researchers report.
A Cardiff University scientist has successfully cloned a human virus offering new hope for the development of treatments for life-threatening diseases.
Cell Therapeutics, Inc. intends to appeal the FDA's decision to require an additional clinical trial for pixantrone to treat patients with relapsed/refractory aggressive non-Hodgkin's lymphoma.
Bacteria that have been made resistant to nearly all antibiotics by an alarming new gene have sickened people in three states and are popping up all over the world, health officials reported.
Antibiotics can temporarily upset your stomach, but now it turns out that repeatedly taking them can trigger long-lasting changes in all those good germs that live in your gut.
Thermo Fisher Scientific Inc. has announced the Syncronis HPLC column range. This new range unerringly delivers consistent, predictable separations, from run to run and column to column.
BioTek’s MultiFlo Microplate Dispenser uses multiple technologies to dispense multiple reagents into multiple microplate types. This all-in-one dispenser saves bench space and transfer time, and also eliminates plate setup steps.
Nycomed announced that its US partner Forest Laboratories, Inc. has filed a response to the FDA addressing topics raised in the complete response letter regarding the New Drug Application for roflumilast (Daxas).
Cyclacel Pharmaceuticals Inc. said it has reached a deal with the Food and Drug Administration on a design for a late-stage study of a potential cancer treatment and plans to begin patient enrollment before the end of 2010.
Scientists have solved a long-standing mystery of how cells conduct "quality control" to eliminate the toxic effects of a certain kind of error in protein production. The findings may lead to a better understanding of a host of neurodegenerative diseases.
Scientists at Duke University Medical Center, in conjunction with several other groups, have uncovered a gene associated with myopia in Caucasian people from several different regions, including Dutch, British and Australian subjects.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma study will be presented at the International Melanoma Research Congress.
Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, announced the presentation of positive preclinical data for radezolid at the Interscience Conference on Antimicrobial Agents and Chemotherapy.
Genzyme Corp. said that it is selling its genetic testing business to Laboratory Corp. of America Holdings for $925 million so it can focus on its core growth areas.